Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forum
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forum
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post Job
Jobs posted by me
Users & Profiles
News
Login/Register
Archives:
News
USFDA
Qvents
May 22, 2023
USFDA 483 to IPCA, Silvassa, India (Insp
Qvents
May 18, 2023
Pharmmedica USA, manufacturer and distri
Qvents
May 18, 2023
Astellas’
Qvents
May 15, 2023
FDA Releases Two Discussion Papers to Sp
Qvents
May 11, 2023
USFDA has issued a new
Qvents
May 11, 2023
MedinCell along with Teva gets approval
Qvents
May 4, 2023
Laurus Labs receives in-principle approv
Qvents
May 4, 2023
Teva USA is recalling thirteen lots of F
Qvents
April 30, 2023
Sun Pharma, Halol is recalling one lot o
Qvents Team
April 30, 2023
1
…
8
9
10
11
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
Warning letter / Centaur / July 2023 / Cleaning deficiencies, failure of Quality unit
August 3, 2025
Natco Pharma USFDA 483 Flags Deficiencies in Aseptic Areas, Validation
August 2, 2025
Investigation Docs Outside EDMS, Hold Time Study Lapses: Jubilant USFDA 483
July 29, 2025
Testing sample
July 29, 2025
sad asd
July 25, 2025